$ETSY

Etsy upgraded, TJX downgraded: Wall Street's top analyst calls

Analysts upgraded Etsy (ETSY) to Buy with a $105 target, citing improved growth. Analog Devices (ADI) was upgraded by Seaport and Bernstein, with targets of $425 and $465, respectively, due to AI opportunities. Merck (MRK) was upgraded by Morgan Stanley to Overweight with a $179 target, but downgraded by RBC to Sector Perform with a $150 target. Progressive (PGR) was upgraded to Outperform with a $250 target, while Allstate (ALL) was downgraded to Underperform with a $250 target. TJX (TJX) was d

Original reporting
Published Aug 20, 2026, 1:38 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 20, 2026, 8:49 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Etsy upgraded, TJX downgraded: Wall Street's top analyst calls — source image
Decision brief

The 30-second read

$ETSYBullishLow
01

Why it matters

Collective upgrades and downgrades provide a snapshot of shifting analyst sentiment, but each individual change is modest in scale.

02

Market read

Analyst rating shifts can trigger short‑term price moves, but the overall market impact is limited.

03

What to watch

Potential macro headwinds could dampen the impact of individual analyst actions.

Relevance 5/10Novelty 3/10Timing: today

Background

The article aggregates recent analyst rating changes and price target adjustments across multiple US‑listed companies.

Company-level read

Ticker impact

$ETSYBullishHigh confidence
Context

BofA upgraded Etsy to Buy with a $105 price target, citing management changes and growth improvement.

Expected impact

moderate upside if price approaches $105.

Evidence & confidence

Upgrade and higher target suggest near-term price appreciation.

$ADIBullishHigh confidence
Context

Seaport Research upgraded Analog Devices to Buy, raising the target to $425 on AI data‑center opportunity.

Expected impact

possible rally toward $425.

Evidence & confidence

Analyst upgrade with higher target indicates bullish outlook.

$MRKNeutralMedium confidence
Context

Morgan Stanley upgraded Merck to Overweight with a $179 target, while RBC later downgraded it to Sector Perform with a $150 target.

Expected impact

price may swing between $150‑$179.

Evidence & confidence

Conflicting analyst views could cause short‑term moves.

$PGRBullishMedium confidence
Context

Keefe Bruyette upgraded Progressive to Outperform with a $250 target, citing auto‑policy growth dynamics.

Expected impact

potential modest upside.

Evidence & confidence

Higher target reflects improved outlook.

$AMTBullishHigh confidence
Context

Barclays upgraded American Tower to Overweight with a $198 target, noting low valuations and catalyst potential.

Expected impact

upward pressure toward $198.

Evidence & confidence

Analyst view signals undervaluation.

$TJXBearishHigh confidence
Context

Citi downgraded TJX to Neutral and Gordon Haskett to Accumulate, cutting the target to $154‑$155 after a weak Q2.

Expected impact

downside risk toward $154.

Evidence & confidence

Lower target reflects weaker performance.

$ALLBearishMedium confidence
Context

Keefe Bruyette downgraded Allstate to Underperform with a $250 target, citing liability loss trends.

Expected impact

potential decline toward $250.

Evidence & confidence

Negative outlook on loss ratios.

$COTYBearishHigh confidence
Context

RBC Capital downgraded Coty to Sector Perform with a $3 target after mixed Q4 guidance.

Expected impact

downside pressure toward $3.

Evidence & confidence

Target reduction signals weak outlook.

Market effects

Broad analyst upgrades may lift sentiment in consumer discretionary and technology sectors.

US market focus; limited direct regional effect.

Minor, as changes are company‑specific.

Counterpoint

Some upgrades may be premature given broader market volatility.

Key entities

  • BofA

    Upgraded Etsy to Buy.

  • Seaport Research

    Upgraded Analog Devices to Buy.

  • Morgan Stanley

    Upgraded Merck to Overweight; resumed KDP coverage.

Related articles

$ETSYMedAI 8/10

ETSY Gets a Bullish Upgrade: What Investors Should Know

Oppenheimer upgraded Etsy (ETSY) to Outperform with a $90 price target, citing AI search benefits, product improvements, and app engagement. The firm expects Etsy to achieve high-end GMS guidance. Etsy reported Q2 2026 GMS growth of 7.5% YoY and announced a $2B share repurchase program. The company also plans a restructuring, cutting 12% of its workforce.

$ADIMed

Can ADI's Industrial Segment Sustain Its Momentum Through 2026?

Analog Devices' (ADI) Industrial segment grew 53% YoY to $1.97B in Q3 2026, driven by automation, energy, and aerospace demand. ADI expects high-single-digit sequential growth next quarter. ADI's stock is up 33.5% YTD, trading at a 9.71X forward P/S ratio, above industry average. Analysts project 66.4% YoY earnings growth for fiscal 2026.

$ALLMed

Busy August pushes Allstate’s current aggregate year pre

Allstate reported $748 million in pre-tax catastrophe losses for August 2026, bringing the total to $3.15 billion for the year. The losses were driven by severe weather, with 50% from a single wind and hail event. Allstate has $150 million in catastrophe bonds and $1 billion in reinsurance, but not all losses will qualify to erode these protections.